IVIG therapy is given as an IV infusion. This means a healthcare professional will start an IV line, typically in your arm, ...

Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on ...

This latter effect is important both because therapy in CIDP is usually episodic and because IVIg is typically a more expensive treatment and indefinite monthly infusions would be quite resource ...

In conclusion, we consider that the available data indicate that IVIg is not a lost cause for the therapy of MS 15,16, and that clinical trials are therefore warranted to determine if a ...

The SCIg market is growing rapidly, with KORU Medical Systems outperforming competitors by capturing market share. Read why I ...

Systems (Nasdaq:KRMD) announced today that it signed a development agreement with a global pharmaceutical company.

The agreement is intended for KORU Medical to develop and seek regulatory clearance for a next-generation subcutaneous immunoglobulin (SCIg) therapy infusion system for use with a commercialized ...